Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.4550 (-1.91%) ($7.4550 - $7.4550) on Tue. Apr. 25, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.97% (three month average) | RSI | 32 | Latest Price | $7.4550(-1.91%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.1% a day on average for past five trading days. | Weekly Trend | BCRX declines -6.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(31%) CEMB(24%) XLRE(23%) BND(21%) EWI(21%) | Factors Impacting BCRX price | BCRX will decline at least -1.485% in a week (0% probabilities). VIXM(-19%) VXX(-17%) UUP(-12%) TLT(-12%) EDOC(-10%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.485% (StdDev 2.97%) | Hourly BBV | -0.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-2.82(-137.83%) | Resistance Level | $8.11 | 5 Day Moving Average | $7.48(-0.33%) | 10 Day Moving Average | $7.76(-3.93%) | 20 Day Moving Average | $8.11(-8.08%) | To recent high | -30.9% | To recent low | 0.9% | Market Cap | $1.315b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |